A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy
暂无分享,去创建一个
Nathalie Jette | Lawrence Korngut | N. Jetté | T. Pringsheim | J. Dykeman | J. Mah | Tamara Pringsheim | L. Korngut | Jonathan Dykeman | Jean K. Mah | Lundy Day | L. Day
[1] Wolfgang Viechtbauer,et al. Conducting Meta-Analyses in R with the metafor Package , 2010 .
[2] P. Beighton,et al. Duchenne and Becker muscular dystrophy prevalence in South Africa and molecular findings in 128 persons affected. , 1994, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[3] David T. Okou,et al. Microarray‐based mutation detection in the dystrophin gene , 2008, Human mutation.
[4] Emery. Diagnostic Criteria for Neuromuscular Disorders , 1997 .
[5] N. Nevin,et al. The prevalence of inherited neuromuscular disease in Northern Ireland , 1996, Neuromuscular Disorders.
[6] I. Talvik,et al. A descriptive epidemiological study of Duchenne muscular dystrophy in childhood in Estonia. , 2003, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[7] E. Khedr,et al. Epidemiological Study of Muscular Disorders in Assiut, Egypt , 2005, Neuroepidemiology.
[8] S. Pandya,et al. Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007. , 2009, MMWR. Morbidity and mortality weekly report.
[9] C. Greenberg,et al. GENE STUDIES IN NEWBORN MALES WITH DUCHENNE MUSCULAR DYSTROPHY DETECTED BY NEONATAL SCREENING , 1988, The Lancet.
[10] A. Green,et al. The Duchenne muscular dystrophy population in Denmark, 1977–2001: prevalence, incidence and survival in relation to the introduction of ventilator use , 2003, Neuromuscular Disorders.
[11] D. Zwijnenburg,et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.
[12] Michael H. Boyle,et al. Guidelines for evaluating prevalence studies , 1998 .
[13] M. Osame,et al. Epidemiology of progressive muscular dystrophy in Okinawa, Japan. Classification with molecular biological techniques. , 1991, Neuroepidemiology.
[14] A. Emery. Population frequencies of inherited neuromuscular diseases—A world survey , 1991, Neuromuscular Disorders.
[15] K. Bushby,et al. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. , 2009, Brain : a journal of neurology.
[16] N. Darín,et al. Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden , 2000, Neuromuscular Disorders.
[17] Hude Quan,et al. Recommendations for optimal ICD codes to study neurologic conditions , 2012, Neurology.
[18] V. Wong,et al. Prevalence of Neuromuscular Diseases in Chinese Children: A Study in Southern China , 2003, Journal of child neurology.
[19] Zhujun Zhang,et al. Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center , 2010, Journal of Human Genetics.
[20] A. McCormick,et al. A Population-Based Study of Dystrophin Mutations in Canada , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[21] R. Gelber,et al. Meta-analysis: the fashion of summing-up evidence. Part I. Rationale and conduct. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] P. Thomas,et al. Classification of neuromuscular diseases , 1988, Journal of the Neurological Sciences.
[23] L. Murri,et al. Epidemiology of dystrophinopathies in North‐West Tuscany: a molecular genetics‐based revisitation , 1999, Clinical genetics.
[24] M. Thambyayah,et al. Prevalence and incidence of Becker muscular dystrophy , 1991, The Lancet.